These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 31811749

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX, Zhang X, Miao RC, Xiang XH, Fu YN, Zhang JY, Liu C, Qu K.
    World J Gastroenterol; 2019 Jan 14; 25(2):220-232. PubMed ID: 30670911
    [Abstract] [Full Text] [Related]

  • 26. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer.
    Liu T, Zhang X, Gao S, Jing F, Yang Y, Du L, Zheng G, Li P, Li C, Wang C.
    Oncotarget; 2016 Dec 20; 7(51):85551-85563. PubMed ID: 27888803
    [Abstract] [Full Text] [Related]

  • 27. Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma.
    Zheng ZK, Pang C, Yang Y, Duan Q, Zhang J, Liu WC.
    J Int Med Res; 2018 Jan 20; 46(1):348-356. PubMed ID: 28856933
    [Abstract] [Full Text] [Related]

  • 28. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma.
    Peng W, Fan H.
    Biomed Pharmacother; 2015 May 20; 72():113-8. PubMed ID: 26054684
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of serum exosomal LncRNA-based biomarker panel for diagnosis and recurrence prediction of bladder cancer.
    Zhang S, Du L, Wang L, Jiang X, Zhan Y, Li J, Yan K, Duan W, Zhao Y, Wang L, Wang Y, Shi Y, Wang C.
    J Cell Mol Med; 2019 Feb 20; 23(2):1396-1405. PubMed ID: 30467945
    [Abstract] [Full Text] [Related]

  • 30. Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma.
    Wang K, Guo WX, Li N, Gao CF, Shi J, Tang YF, Shen F, Wu MC, Liu SR, Cheng SQ.
    PLoS One; 2015 Feb 20; 10(12):e0144934. PubMed ID: 26674525
    [Abstract] [Full Text] [Related]

  • 31. The diagnostic value of plasma exosomal hsa_circ_0070396 for hepatocellular carcinoma.
    Lyu L, Yang W, Yao J, Wang H, Zhu J, Jin A, Liu T, Wang B, Zhou J, Fan J, Yang X, Guo W.
    Biomark Med; 2021 Apr 20; 15(5):359-371. PubMed ID: 33666515
    [Abstract] [Full Text] [Related]

  • 32. Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma.
    Kamel MM, Matboli M, Sallam M, Montasser IF, Saad AS, El-Tawdi AHF.
    Transl Res; 2016 Feb 20; 168():134-145. PubMed ID: 26551349
    [Abstract] [Full Text] [Related]

  • 33. Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma.
    Xie H, Ma H, Zhou D.
    Biomed Res Int; 2013 Feb 20; 2013():136106. PubMed ID: 23762823
    [Abstract] [Full Text] [Related]

  • 34. HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma.
    Li J, Wang X, Tang J, Jiang R, Zhang W, Ji J, Sun B.
    Cell Physiol Biochem; 2015 Feb 20; 37(2):687-96. PubMed ID: 26356260
    [Abstract] [Full Text] [Related]

  • 35. Serum lnc34a is a potential prediction biomarker for bone metastasis in hepatocellular carcinoma patients.
    Zhang L, Niu H, Yang P, Ma J, Yuan BY, Zeng ZC, Xiang ZL.
    BMC Cancer; 2021 Feb 15; 21(1):161. PubMed ID: 33588789
    [Abstract] [Full Text] [Related]

  • 36. Exosomes and Hepatocellular Carcinoma: From Bench to Bedside.
    Sasaki R, Kanda T, Yokosuka O, Kato N, Matsuoka S, Moriyama M.
    Int J Mol Sci; 2019 Mar 20; 20(6):. PubMed ID: 30897788
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Role of exosomal competing endogenous RNA in patients with hepatocellular carcinoma.
    Abd El Gwad A, Matboli M, El-Tawdi A, Habib EK, Shehata H, Ibrahim D, Tash F.
    J Cell Biochem; 2018 Nov 20; 119(10):8600-8610. PubMed ID: 30015383
    [Abstract] [Full Text] [Related]

  • 39. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM, Teng F.
    Int J Clin Exp Pathol; 2015 Nov 20; 8(4):4008-14. PubMed ID: 26097588
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.